{"id":"W2607115439","doi":"10.1016/j.eururo.2017.03.021","title":"An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":false,"ca_institutions":"Genome British Columbia; Zymeworks (Canada); University of British Columbia","funders":"H. Lundbeck A/S; Lundbeckfonden; Prostate Cancer Canada","keywords":"Medicine; Cisplatin; Oncofetal antigen; Bladder cancer; Oncology; Internal medicine; Cancer research; Cancer; Chemotherapy; Immunotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005279171,0.0003038119,0.0002345898,0.0001161432,0.0006447888,0.0004273099,0.002033983,0.0001358916,0.0001199974],"category_scores_gemma":[0.0001834653,0.0002772286,0.00009342729,0.00007703207,0.0003041301,0.00004142835,0.0005697769,0.0002357338,0.0001003753],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003285722,"about_ca_system_score_gemma":0.0001869383,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004271852,"about_ca_topic_score_gemma":0.0009705567,"domain_scores_codex":[0.9974301,0.0004324548,0.0003226235,0.0009092193,0.0002563766,0.0006491971],"domain_scores_gemma":[0.9974408,0.00001764194,0.00020989,0.001809518,0.0001905427,0.0003316274],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001215681,0.0001737316,0.006633714,0.00001826685,0.0001289464,0.00006246759,0.0001320083,0.00038629,0.8974299,0.0003474333,0.001879709,0.09159187],"study_design_scores_gemma":[0.00209051,0.003808239,0.5681288,0.00001863739,0.00009655066,0.00004580191,0.00005816,0.001523602,0.1083732,0.0002124662,0.3146068,0.001037225],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9790151,0.000480408,0.004173565,0.003420139,0.0003342253,0.0007766092,0.0001006189,0.00004742005,0.01165189],"genre_scores_gemma":[0.9953061,0.0001162584,0.0002834917,0.001948888,0.0007436267,0.0001347901,0.0001142255,0.00008917219,0.001263484],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7890567,"threshold_uncertainty_score":0.999968,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06121569020570082,"score_gpt":0.3822384388406729,"score_spread":0.321022748634972,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}